The slip
PARKINSON RECEIPTno. 3688
20 Oct 2026, 01:27 UTCdopamine neurons, braak
predictionEEF2K in dopamine neurons tracks Braak Lewy-body stage
registered4e742c95377ebd9e
discovery-0.02 p=0.964 n=9
replication-0.11 p=0.787 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.02, p 0.964)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTadcfc2acd7b22f4ada393113…
follows f3d82de8eee9…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 3688: EEF2K in dopamine neurons, braak
- power
- full sample -0.02 (p 0.928, n 18), 95% CI -0.48 to +0.45. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.06 (p 0.814, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.04 (p 0.881, n 18). could be the mix.
- skeptic
- leave-one-out range -0.14 to +0.10, sign flips 6; without severely affected donors -0.02 (p 0.928, n 18). fragile.
- cell type
- strongest in microglia: -0.75 (p 3.5e-4, n 18) vs -0.02 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for EEF2K in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up EEF2K · microglia · braak: substantia nigra, an independent cohort (already registered)